Completed PHASE2 INTERVENTIONAL 2-arm NCT00119197

Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata

Safety and Immunogenicity of a Killed, Oral Cholera Vaccine in Indian Subjects in Eastern Kolkata, West Bengal

Sponsor: Indian Council of Medical Research

Conditions Cholera

Interventions Heat Killed E. coli killed whole cell oral cholera vaccine

Updated 6 times since 2017 Last updated: Jun 26, 2008 Started: Aug 31, 2005 Primary completion: Jun 30, 2006 Completion: Jul 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cholera, this trial is completed. The trial is conducted by Indian Council of Medical Research and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2
Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indian Council of Medical Research
International Vaccine Institute
National Institute of Cholera and Enteric Diseases, India
Shantha Biotechnics Limited

Data source: International Vaccine Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kolkata, India